Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearSign Technologies (CLIR) Asset Writedowns and Impairment (2016 - 2024)

Historic Asset Writedowns and Impairment for ClearSign Technologies (CLIR) over the last 8 years, with Q4 2024 value amounting to $3000.0.

  • ClearSign Technologies' Asset Writedowns and Impairment fell 9552.24% to $3000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $87000.0, marking a year-over-year decrease of 7238.1%. This contributed to the annual value of $20000.0 for FY2024, which is 7530.86% down from last year.
  • Per ClearSign Technologies' latest filing, its Asset Writedowns and Impairment stood at $3000.0 for Q4 2024, which was down 9552.24% from $17000.0 recorded in Q3 2024.
  • ClearSign Technologies' 5-year Asset Writedowns and Impairment high stood at $248000.0 for Q4 2021, and its period low was $3000.0 during Q4 2024.
  • Moreover, its 3-year median value for Asset Writedowns and Impairment was $42000.0 (2023), whereas its average is $83750.0.
  • Data for ClearSign Technologies' Asset Writedowns and Impairment shows a peak YoY increase of 9552.24% (in 2024) and a maximum YoY decrease of 9552.24% (in 2024) over the last 5 years.
  • Over the past 3 years, ClearSign Technologies' Asset Writedowns and Impairment (Quarter) stood at $248000.0 in 2021, then crashed by 72.98% to $67000.0 in 2023, then tumbled by 95.52% to $3000.0 in 2024.
  • Its Asset Writedowns and Impairment stands at $3000.0 for Q4 2024, versus $17000.0 for Q3 2024 and $67000.0 for Q4 2023.